Header Logo

Jeffrey Rade

Concepts (379)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aspirin
9
2024
170
3.190
Why?
Platelet Aggregation Inhibitors
13
2021
209
3.050
Why?
Thromboxane B2
7
2024
19
2.390
Why?
Coronary Artery Bypass
7
2017
246
2.170
Why?
Graft Occlusion, Vascular
6
2016
58
1.880
Why?
Saphenous Vein
5
2016
37
1.770
Why?
Blood Platelets
7
2021
169
1.700
Why?
Percutaneous Coronary Intervention
9
2021
107
1.640
Why?
Acute Coronary Syndrome
6
2021
277
1.550
Why?
Myocardial Infarction
11
2020
805
1.540
Why?
Thromboxanes
5
2024
9
1.540
Why?
Thrombomodulin
7
2011
15
1.530
Why?
Coronary Artery Disease
6
2021
242
1.370
Why?
Thromboxane A2
2
2017
7
1.100
Why?
Thrombosis
6
2020
173
1.090
Why?
Cardiac Catheterization
5
2021
165
1.080
Why?
Cardiovascular Diseases
3
2022
717
1.010
Why?
Ticlopidine
3
2013
61
0.910
Why?
Endothelial Cells
3
2011
161
0.910
Why?
Angioplasty, Balloon, Coronary
5
2020
130
0.860
Why?
Endothelium, Vascular
6
2009
148
0.840
Why?
Venous Thrombosis
3
2011
105
0.780
Why?
Ventricular Function, Left
1
2022
182
0.770
Why?
Myocardial Revascularization
1
2020
69
0.740
Why?
Mechanotransduction, Cellular
2
2011
29
0.740
Why?
Myocardial Ischemia
2
2012
97
0.720
Why?
Platelet Activation
5
2019
86
0.710
Why?
Electrocardiography
2
2020
366
0.710
Why?
ST Elevation Myocardial Infarction
4
2021
58
0.700
Why?
Coronary Disease
3
2014
234
0.700
Why?
Purinergic P2Y Receptor Antagonists
3
2021
19
0.680
Why?
Biomarkers
7
2020
1034
0.680
Why?
Male
37
2022
24077
0.670
Why?
Humans
53
2024
52859
0.660
Why?
Time Factors
14
2020
3235
0.660
Why?
Middle Aged
24
2022
14044
0.650
Why?
Fractional Flow Reserve, Myocardial
2
2015
13
0.630
Why?
Heart Failure
3
2022
683
0.620
Why?
Platelet Factor 4
2
2009
10
0.610
Why?
Aged
21
2022
11563
0.600
Why?
NF-kappa B
3
2009
429
0.600
Why?
Human Umbilical Vein Endothelial Cells
2
2018
32
0.590
Why?
Risk Factors
10
2020
4472
0.580
Why?
Heparin
2
2009
96
0.580
Why?
Treatment Outcome
15
2020
4219
0.580
Why?
Receptors, Purinergic P2Y12
2
2013
16
0.570
Why?
Creatinine
3
2024
117
0.560
Why?
Jugular Veins
3
2011
24
0.520
Why?
Stress, Mechanical
3
2011
125
0.490
Why?
Pyridines
1
2014
86
0.490
Why?
Female
28
2022
27487
0.480
Why?
Cells, Cultured
11
2021
2026
0.480
Why?
Cyclooxygenase 1
1
2013
17
0.470
Why?
Hematocrit
1
2013
33
0.470
Why?
Adenoviridae
9
2008
108
0.440
Why?
Genetic Therapy
5
2008
598
0.430
Why?
Blood Pressure
2
2006
491
0.430
Why?
Drug Resistance, Multiple
1
2012
32
0.420
Why?
Anterior Wall Myocardial Infarction
1
2011
5
0.410
Why?
Quinazolines
1
2011
15
0.400
Why?
Myocardium
3
2020
193
0.400
Why?
Transforming Growth Factor beta1
1
2011
48
0.400
Why?
Thiophenes
1
2011
41
0.390
Why?
Drug-Eluting Stents
1
2011
32
0.390
Why?
Drug Resistance
1
2011
87
0.390
Why?
Fatty Acid-Binding Proteins
1
2010
19
0.390
Why?
Piperazines
1
2011
86
0.380
Why?
Matrix Metalloproteinase 1
2
2021
8
0.360
Why?
Antibodies, Neutralizing
1
2011
182
0.360
Why?
Receptor, PAR-1
2
2020
8
0.350
Why?
Proteasome Inhibitors
1
2009
30
0.350
Why?
Boronic Acids
1
2009
24
0.350
Why?
Cyclooxygenase 2
1
2009
70
0.350
Why?
Pyrazines
1
2009
30
0.350
Why?
Kruppel-Like Transcription Factors
1
2009
46
0.350
Why?
Prognosis
3
2024
1291
0.340
Why?
Fibroblast Growth Factor 4
2
2008
7
0.340
Why?
Gene Expression Regulation, Enzymologic
1
2009
122
0.340
Why?
Gene Expression Regulation
4
2005
1487
0.340
Why?
Protease Inhibitors
1
2009
101
0.330
Why?
Platelet Aggregation
4
2013
56
0.330
Why?
Hirudins
3
1999
7
0.330
Why?
Prasugrel Hydrochloride
3
2021
21
0.320
Why?
Angina Pectoris
2
2005
35
0.320
Why?
Atherosclerosis
2
2021
137
0.320
Why?
Neovascularization, Physiologic
2
2008
99
0.320
Why?
Stents
2
2020
349
0.300
Why?
Endocardium
1
2006
8
0.300
Why?
Predictive Value of Tests
3
2017
857
0.290
Why?
Surgical Procedures, Operative
1
2008
145
0.290
Why?
Follow-Up Studies
5
2020
1990
0.290
Why?
Heart Rate
3
2006
269
0.290
Why?
Lipopeptides
3
2021
17
0.280
Why?
Antineoplastic Agents
1
2011
533
0.280
Why?
Genetic Vectors
9
2008
663
0.280
Why?
United States
8
2021
6773
0.280
Why?
Cell-Penetrating Peptides
3
2021
27
0.280
Why?
Risk Assessment
5
2019
1644
0.250
Why?
Antibody Formation
1
2005
106
0.250
Why?
Multivariate Analysis
2
2017
853
0.250
Why?
Interleukin-1
1
2005
151
0.240
Why?
Tumor Necrosis Factor-alpha
2
2018
554
0.240
Why?
Coronary Circulation
3
2011
43
0.240
Why?
Vascular Patency
2
2016
118
0.240
Why?
Inflammation Mediators
1
2005
155
0.240
Why?
Angina, Unstable
1
2003
65
0.230
Why?
Registries
3
2021
709
0.230
Why?
Cloning, Molecular
1
2003
352
0.220
Why?
Estrogen Replacement Therapy
1
2003
94
0.220
Why?
Feedback, Physiological
1
2003
55
0.220
Why?
Prospective Studies
6
2021
2710
0.220
Why?
Animals
17
2021
18203
0.220
Why?
Estrogens
1
2003
113
0.220
Why?
Progesterone
1
2003
154
0.210
Why?
Antithrombins
2
1999
14
0.210
Why?
Retroviridae
2
1999
68
0.210
Why?
Muscle, Smooth, Vascular
4
2011
38
0.210
Why?
Kidney
1
2024
364
0.210
Why?
Stroke Volume
2
2022
241
0.210
Why?
Proto-Oncogene Proteins
4
2005
280
0.210
Why?
Rabbits
3
2011
296
0.210
Why?
Adenosine Diphosphate
2
2013
53
0.200
Why?
Fibrillar Collagens
1
2021
1
0.200
Why?
Pandemics
3
2020
541
0.200
Why?
Serine Endopeptidases
1
2021
70
0.190
Why?
Coronary Angiography
2
2011
132
0.190
Why?
Troponin
1
2020
28
0.190
Why?
Gene Transfer Techniques
5
2008
265
0.190
Why?
Protein C
2
2011
28
0.190
Why?
Aorta
1
2021
93
0.190
Why?
Carotid Arteries
3
2011
60
0.180
Why?
Collagen
2
2011
127
0.180
Why?
Clinical Trials as Topic
2
2015
378
0.180
Why?
Out-of-Hospital Cardiac Arrest
1
2020
37
0.170
Why?
Monocytes
1
2021
330
0.170
Why?
Adult
8
2021
13788
0.160
Why?
Matrix Metalloproteinase 13
1
2018
6
0.160
Why?
Influenza A virus
1
2019
115
0.160
Why?
Gene Expression
4
1999
760
0.160
Why?
Carotid Artery Diseases
1
2018
52
0.160
Why?
Urinalysis
1
2017
33
0.160
Why?
Aortic Diseases
1
2018
63
0.150
Why?
Coronavirus Infections
1
2020
179
0.150
Why?
Cause of Death
1
2017
168
0.150
Why?
Prevalence
1
2020
1142
0.150
Why?
Pneumonia, Viral
1
2020
190
0.150
Why?
Oxidative Stress
2
2016
249
0.150
Why?
Recurrence
3
2021
501
0.140
Why?
Influenza, Human
1
2019
185
0.140
Why?
Cyclooxygenase Inhibitors
2
2013
40
0.140
Why?
Kaplan-Meier Estimate
1
2017
354
0.140
Why?
Rats
5
2006
1723
0.140
Why?
Carotid Artery Injuries
1
1996
9
0.140
Why?
Dinoprost
1
2016
15
0.140
Why?
Atrioventricular Node
3
2006
8
0.140
Why?
Proportional Hazards Models
1
2017
620
0.140
Why?
Apoptosis
1
2021
963
0.140
Why?
Hospitalization
2
2021
1161
0.140
Why?
Coronary Stenosis
1
2015
30
0.130
Why?
Neovascularization, Pathologic
1
1996
123
0.130
Why?
Disease Models, Animal
4
2021
1829
0.130
Why?
Retrospective Studies
3
2020
5141
0.120
Why?
Tomography, X-Ray Computed
2
2011
1226
0.120
Why?
Cardiac Care Facilities
1
2014
2
0.120
Why?
Radial Artery
1
2014
28
0.120
Why?
Receptors, Thromboxane A2, Prostaglandin H2
1
2013
1
0.120
Why?
Stroke
2
2021
963
0.110
Why?
Practice Patterns, Physicians'
1
2019
711
0.110
Why?
Aged, 80 and over
6
2021
4463
0.110
Why?
Professional Competence
1
2014
81
0.110
Why?
GTP-Binding Protein alpha Subunits, Gi-Go
2
2004
13
0.110
Why?
Troponin I
2
2010
23
0.110
Why?
Antibody Specificity
1
2012
94
0.110
Why?
Cross Reactions
1
2012
142
0.110
Why?
Chromatography, Liquid
1
2012
107
0.110
Why?
Tandem Mass Spectrometry
1
2012
107
0.110
Why?
Aldehyde Reductase
1
2011
4
0.100
Why?
Paracrine Communication
1
2011
13
0.100
Why?
Contraindications
1
2011
38
0.100
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
436
0.100
Why?
Regional Blood Flow
1
2011
86
0.100
Why?
Carcinoid Tumor
1
2011
15
0.100
Why?
Platelet Count
1
2011
31
0.100
Why?
Myocytes, Smooth Muscle
1
2011
56
0.100
Why?
Creatine Kinase, MB Form
1
2010
10
0.100
Why?
Fatty Acid Binding Protein 3
1
2010
3
0.100
Why?
Treatment Failure
1
2011
174
0.100
Why?
Polymorphism, Single Nucleotide
1
2013
418
0.100
Why?
Chi-Square Distribution
1
2011
386
0.100
Why?
Myoglobin
1
2010
26
0.100
Why?
Neoplasm Metastasis
1
2011
185
0.100
Why?
Molecular Sequence Data
3
2013
1889
0.090
Why?
Perioperative Care
1
2011
63
0.090
Why?
DNA, Complementary
2
2003
159
0.090
Why?
Health Personnel
1
2014
335
0.090
Why?
Mice, Knockout, ApoE
2
2021
2
0.090
Why?
Sensitivity and Specificity
1
2012
1000
0.090
Why?
Shear Strength
1
2009
17
0.090
Why?
Plaque, Atherosclerotic
2
2021
36
0.090
Why?
Ventricular Dysfunction, Left
1
2010
123
0.090
Why?
Bortezomib
1
2009
45
0.090
Why?
Odds Ratio
1
2011
779
0.090
Why?
Mice, Inbred C3H
1
2009
161
0.090
Why?
Epinephrine
1
2009
41
0.090
Why?
Tissue Plasminogen Activator
2
2000
102
0.080
Why?
Sex Factors
1
2011
865
0.080
Why?
Randomized Controlled Trials as Topic
3
2021
562
0.080
Why?
Blood Glucose
1
2011
468
0.080
Why?
Thrombocytopenia
1
2009
51
0.080
Why?
Mice, Inbred C57BL
3
2021
2944
0.080
Why?
Cardiac Surgical Procedures
1
2011
155
0.080
Why?
Survival Rate
2
2014
665
0.080
Why?
Collateral Circulation
1
2008
21
0.080
Why?
Antibodies, Monoclonal
1
2012
774
0.080
Why?
Logistic Models
1
2011
1203
0.080
Why?
Mice
3
2021
9538
0.080
Why?
Serotonin
2
2005
59
0.080
Why?
Base Sequence
2
2003
1242
0.080
Why?
Disease Progression
2
2018
831
0.070
Why?
Bundle of His
1
2006
2
0.070
Why?
Bundle-Branch Block
1
2006
5
0.070
Why?
Myocardial Contraction
1
2006
74
0.070
Why?
Rats, Wistar
1
2006
167
0.070
Why?
Amino Acid Sequence
2
2013
1516
0.070
Why?
Patient Selection
1
2008
368
0.070
Why?
RNA, Messenger
1
2011
1391
0.070
Why?
Immune Complex Diseases
1
2005
2
0.070
Why?
Myocardial Stunning
1
2005
6
0.070
Why?
E1A-Associated p300 Protein
1
2005
6
0.070
Why?
Proto-Oncogene Proteins c-ets
1
2005
20
0.060
Why?
Catecholamines
1
2005
27
0.060
Why?
Purpura, Thrombocytopenic, Idiopathic
1
2005
20
0.060
Why?
Chronic Disease
1
2008
681
0.060
Why?
Neuropeptides
1
2005
74
0.060
Why?
Nitric Oxide Donors
1
2003
4
0.060
Why?
Fibrinolytic Agents
2
2018
143
0.060
Why?
Cysteine Proteinase Inhibitors
1
2003
19
0.060
Why?
Vascular Cell Adhesion Molecule-1
1
2003
13
0.060
Why?
E-Selectin
1
2003
18
0.060
Why?
Cohort Studies
1
2009
2188
0.060
Why?
Intercellular Adhesion Molecule-1
1
2003
48
0.060
Why?
Fibroblast Growth Factors
1
2003
58
0.060
Why?
In Vitro Techniques
2
2011
426
0.060
Why?
Vinblastine
1
2003
13
0.060
Why?
Leukopenia
1
2003
16
0.060
Why?
Sequence Homology, Amino Acid
1
2003
337
0.060
Why?
Double-Blind Method
2
2020
559
0.060
Why?
Trans-Activators
1
2005
286
0.060
Why?
Granulocytes
1
2003
64
0.060
Why?
Vasculitis
1
2003
46
0.050
Why?
Sequence Analysis, DNA
1
2003
366
0.050
Why?
Promoter Regions, Genetic
1
2005
612
0.050
Why?
Drug Therapy, Combination
1
2003
364
0.050
Why?
Adenoviridae Infections
2
2003
3
0.050
Why?
Models, Animal
1
2003
206
0.050
Why?
Hemodynamics
1
2003
175
0.050
Why?
A549 Cells
1
2021
29
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
492
0.050
Why?
Cell Line
2
2018
1936
0.050
Why?
Postmenopause
1
2003
296
0.050
Why?
North America
1
2021
111
0.050
Why?
Microscopy, Electron, Transmission
1
2021
135
0.050
Why?
Stress, Psychological
1
2005
398
0.050
Why?
Canada
1
2021
122
0.050
Why?
Fibrosis
1
2021
107
0.050
Why?
Proof of Concept Study
1
2020
30
0.050
Why?
Antiviral Agents
1
2003
308
0.050
Why?
Transfection
2
1999
629
0.050
Why?
Signal Transduction
3
2018
2720
0.050
Why?
Reoperation
1
2021
211
0.050
Why?
Atrial Fibrillation
2
2004
594
0.050
Why?
Infusions, Intravenous
1
2020
155
0.050
Why?
Necrosis
1
2020
124
0.050
Why?
Arrhythmias, Cardiac
1
2000
99
0.050
Why?
Hospitals, High-Volume
1
2020
27
0.050
Why?
Blotting, Western
1
2021
550
0.050
Why?
Hirudin Therapy
1
1999
1
0.050
Why?
Megakaryocytes
1
1999
19
0.050
Why?
Nuclear Proteins
1
2005
739
0.050
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
1999
50
0.040
Why?
Cell Division
1
2000
402
0.040
Why?
Host-Pathogen Interactions
1
2021
226
0.040
Why?
Growth Hormone
1
1999
46
0.040
Why?
Protein Sorting Signals
1
1999
51
0.040
Why?
Extracellular Traps
1
2019
32
0.040
Why?
Complement C3
1
2019
59
0.040
Why?
Matrix Metalloproteinase Inhibitors
1
2018
4
0.040
Why?
Clinical Trials, Phase II as Topic
1
2018
21
0.040
Why?
Toll-Like Receptor 7
1
2019
97
0.040
Why?
Hydroxamic Acids
1
2018
24
0.040
Why?
Hospitals
1
2021
345
0.040
Why?
Rats, Sprague-Dawley
2
1997
512
0.040
Why?
Blood Vessel Prosthesis
1
1999
186
0.040
Why?
Multicenter Studies as Topic
1
2018
94
0.040
Why?
Oligopeptides
1
2018
125
0.040
Why?
Mass Spectrometry
1
1999
259
0.040
Why?
Drug Utilization
1
2019
222
0.040
Why?
Drug Prescriptions
1
2019
187
0.040
Why?
Adenoviruses, Human
1
1997
8
0.040
Why?
Carotid Artery, Common
1
1997
21
0.040
Why?
Comorbidity
1
2020
1013
0.040
Why?
Transcription Factors
1
2005
1374
0.040
Why?
Neutrophils
1
2019
330
0.040
Why?
Hospital Mortality
1
2021
803
0.040
Why?
Recombinant Proteins
2
1996
654
0.040
Why?
Membrane Glycoproteins
1
2019
600
0.030
Why?
Healthcare Disparities
1
2019
300
0.030
Why?
Mice, Knockout
1
2019
1924
0.030
Why?
Dose-Response Relationship, Radiation
1
2014
44
0.030
Why?
Learning Curve
1
2014
23
0.030
Why?
beta-Galactosidase
1
1993
72
0.030
Why?
Femoral Artery
1
2014
74
0.030
Why?
Binding, Competitive
1
2013
101
0.030
Why?
Massachusetts
1
2019
2009
0.030
Why?
GTP-Binding Protein alpha Subunit, Gi2
2
2004
5
0.030
Why?
Genetic Association Studies
1
2013
107
0.030
Why?
Models, Biological
2
2011
1091
0.030
Why?
Protein Structure, Secondary
1
2013
239
0.030
Why?
Amino Acid Substitution
1
2013
242
0.030
Why?
Proteome
1
2013
117
0.030
Why?
Phosphoproteins
1
2013
200
0.030
Why?
Phospholipase C gamma
1
2011
9
0.030
Why?
Mitogen-Activated Protein Kinase 14
1
2011
8
0.030
Why?
Young Adult
1
2021
3818
0.030
Why?
Protein Structure, Tertiary
1
2013
635
0.030
Why?
Coronary Artery Bypass, Off-Pump
1
2011
5
0.020
Why?
Platelet Transfusion
1
2011
12
0.020
Why?
Protein Kinase C
1
2011
94
0.020
Why?
Emergency Treatment
1
2011
42
0.020
Why?
Binding Sites
1
2013
831
0.020
Why?
Reactive Oxygen Species
1
2011
174
0.020
Why?
Adolescent
1
2021
5400
0.020
Why?
Enzyme Inhibitors
1
2011
319
0.020
Why?
Models, Molecular
1
2013
1075
0.020
Why?
Case-Control Studies
1
2011
963
0.020
Why?
Evidence-Based Medicine
1
2011
403
0.020
Why?
Diabetes Mellitus
1
2011
523
0.020
Why?
Creatine Kinase
1
2005
39
0.020
Why?
Diltiazem
1
2004
3
0.020
Why?
Propanolamines
1
2004
10
0.020
Why?
Digoxin
1
2004
14
0.020
Why?
Sus scrofa
1
2004
25
0.020
Why?
Cardiac Pacing, Artificial
1
2004
23
0.020
Why?
Drug Administration Schedule
1
2005
250
0.020
Why?
Anti-Arrhythmia Agents
1
2004
31
0.020
Why?
Chest Pain
1
2005
72
0.020
Why?
Survival Analysis
1
2005
473
0.010
Why?
Nitrogen Oxides
1
2003
6
0.010
Why?
Dithiothreitol
1
2003
14
0.010
Why?
Hydrazines
1
2003
11
0.010
Why?
Injections, Intra-Arterial
1
2003
17
0.010
Why?
Technetium Tc 99m Sestamibi
1
2003
28
0.010
Why?
Cysteine Endopeptidases
1
2003
77
0.010
Why?
Dose-Response Relationship, Drug
1
2005
732
0.010
Why?
Adenosine
1
2003
65
0.010
Why?
Nitric Oxide
1
2003
114
0.010
Why?
Radiopharmaceuticals
1
2003
141
0.010
Why?
Recombinant Fusion Proteins
1
2004
464
0.010
Why?
Acute Disease
1
2004
622
0.010
Why?
Ultrasonography
1
2004
414
0.010
Why?
Diagnosis, Differential
1
2005
777
0.010
Why?
HeLa Cells
1
2003
503
0.010
Why?
Peptide Fragments
1
2003
329
0.010
Why?
Tomography, Emission-Computed, Single-Photon
1
2003
178
0.010
Why?
Viral Proteins
1
2003
258
0.010
Why?
Transformation, Genetic
1
2000
27
0.010
Why?
Electric Conductivity
1
2000
39
0.010
Why?
Electrophysiology
1
2000
72
0.010
Why?
Papio
1
1999
12
0.010
Why?
Cattle
1
2000
293
0.010
Why?
Swine
1
2000
302
0.010
Why?
Postoperative Complications
1
2005
969
0.010
Why?
Arteritis
1
1997
4
0.010
Why?
Neutralization Tests
1
1997
126
0.010
Why?
Immunization
1
1997
118
0.010
Why?
Ultraviolet Rays
1
1997
112
0.010
Why?
Antibodies, Viral
1
1997
299
0.010
Why?
Cell Differentiation
1
1999
1245
0.010
Why?
Rats, Inbred F344
1
1993
55
0.010
Why?
Rade's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (379)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_